International Medica Foundation’s Vaccine for Newborns Demonstrates Early Protection against Rotavirus

12:51 EDT 18 Jun 2013 | Businesswire
This article has expired, however you can still download the PDF.
Preview:
Vaccine to address the global problem of deadly diarrhea in infants The International Medica Foundation announced today that for the first time in a large clinical trial of 998 young infants, its rotavirus vaccine was very e...

Other Sources for this Article

International Medica Foundation
Dr. Leonard Ruiz, +1 651-490-0212
LPRuiz@intl-medica.org
www.intl-medica.org

NEXT ARTICLE

More From BioPortfolio on "International Medica Foundation’s Vaccine for Newborns Demonstrates Early Protection against Rotavirus"

Search BioPortfolio:
Advertisement

Relevant Topic

Vaccine
Latest News Clinical Trials Research Drugs Reports Corporate
A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one...

Advertisement

Searches Linking to this Story